B-LCL-HROC173 Cells


General information
Description | The cell line was derived from the peripheral blood of a patient with CRC. |
---|---|
Organism | Human |
Tissue | Peripheral blood |
Disease | Carcinoma |
Synonyms | TiBc HROC173 |
Characteristics
Age | 45 years |
---|---|
Gender | Male |
Ethnicity | Caucasian |
Morphology | Round cells |
Cell type | B lymphoblast |
Growth properties | Suspension |
Identifiers / Biosafety / Citation
Citation | B-LCL-HROC173 (Cytion catalog number 302039) |
---|---|
Biosafety level | 2 |
Expression / Mutation
Viruses | Transformant: EBV |
---|
Handling
Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 10% heat-inactivated FBS |
Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 10^5 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
HLA alleles |
A*: '01:01:01, '30:01:01
B*: '08:01:01, '13:02:01
C*: '06:02:01, '07:01:01
DRB1*: '03:01:01, '07:01:01
DQA1*: '02:01:01, '05:01:01
DQB1*: '02:01:01, '02:02:01
DPB1*: '01:01:01, '17:01:01
E: '01:01:01
|